Samuel E. Dagogo-Jack is a Nigerian-American physician.[1] He is the A.C. Mullins Endowed Professor in Translational Research, Professor of Medicine, and Chief of the Division of Endocrinology, Diabetes, and Metabolism at the University of Tennessee Health Science Center.[2]
He is the director of the Postgraduate Specialist Training Program in Endocrinology, Diabetes, and Metabolism, and of the Clinical Research Unit, Clinical and Translational Research Institute at UTHSC. He was President (Medicine & Science) of the American Diabetes Association in 2015[3] and is a recipient of the Banting Medal for Leadership from the ADA.[4] In 2015, he was named President, Medicine & Science, for the American Diabetes Association (ADA). He is an editor of the Journal of Clinical Endocrinology & Metabolism.
He developed the first radioimmunoassay for an epidermal growth factor (EGF) in human saliva,[6] isolated EGF from mouse thyroid,[7] and worked on the regulation of EGF in mice and humans.[8][9][10][11] His work with Philip E. Cryer led to the discovery of the hypoglycemia-associated autonomic failure syndrome[12] and development of methodology for reversal of hypoglycemia unawareness.[13]